Evidence for inhibition of leptin secretion by catecholamines in man

Experimental and Clinical Endocrinology and Diabetes

Volumn 106, Issue 5, 1998, Pages 415-418

  Fritsche, A ^a   Wahl, H G ^a   Metzinger, E ^a   Renn, W ^a   Kellerer, M ^a   Haring H ^a   Stumvoll, M ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Epinephrine; Free fatty acids; Hyperinsulinemia; Hypoglycemia; Metabolic syndrome; Obesity

Indexed keywords

ADRENALIN; CATECHOLAMINE DERIVATIVE; FATTY ACID; INSULIN; LEPTIN;

ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0031783264     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212008     Document Type: Article

References (22)

1. Arch JR, Wilson S: Prospects for beta 3-adrenoceptor agonists in the treatment of obesity and diabetes. Int J Obes Relat Metab Disord 20: 191-199, 1996
2. Berneis K, Vosmeer S, Keller U: Effects of glucocorticoids and of growth hormone on serum leptin concentrations in man. Eur J Endocrinol 135: 663-665, 1996
3. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295, 1996
4. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M: Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 45: 695-698, 1996
5. Facchini FS, Stoohs RA, Reaven GM: Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 9: 1013-1017, 1996
6. Gerich JE: Glucose counterregulation and its impact on diabetes mellitus. Diabetes 37: 1608-1617, 1988
7. Gerich JE, Bolli GB: Counterregulatory failure. In: Frier B and Fisher M.(eds). Hypoglycemia and diabetes. Clinical and physiological aspects, pp. 253-267, 1993
8. Gettys TW, Harkness PJ, Watson PM: The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 137: 4054-4057, 1996
9. Hamann A, Matthaei S: Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 104: 293-300, 1996
10. Hoffstedt J, Lonnqvist F, Shimizu M, Blaak E, Arner P: Effects of several putative beta 3-adrenoceptor agonists on lipolysis in human omental adipocytes. Int J Obes Relat Metab Disord 20: 428-434, 1996
11. Kiess W, Blum WF, Rascher W: Leptin - the voice of the adipose tissue. Exp Clin Endocrinol Diabetes 105: 314-315, 1997
12. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF: Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 45: 699-701, 1996
13. Krief S, Lonnqvist F, Raimbault S, Baude B, Van-Spronsen A, Amer P, Strosberg AD, Ricquier D, Emorine LJ: Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest 91: 344-349, 1993
14. Lönnqvist F: The obese (ob) gene and its product leptin - a new route toward obesity treatment in man? Q J Med 89: 327-332, 1996
15. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155-1161, 1995
16. Malmström R, Taskinen M-R, Karonen S-L, Yki-Järvinen H: Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 39: 993-996, 1996
17. Miell JP, Englaro P, Blum WF: Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects. Horm Metab Res 28: 704-707, 1996
18. Remesar X, Rafecas I, Fernandez-Lopez JA, Alemany M: Is leptin an insulin counter-regulatory hormone? FEBS Lett 402: 9-11, 1997
19. Rentsch J, Chiesi M: Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 379: 55-59, 1996
20. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro JF: Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 97: 1344-1347, 1996
21. Trayhurn P, Duncan JS, Rayner DV, Hardie LJ: Rapid inhibition of ob gene expression and circulating leptin levels in lean mice by the beta 3-adrenoceptor agonists BRL 35135A and ZD2079. Biochem Biophys Res Commun 228: 605-610, 1996
22. Tremblay A: Differences in fat balance underlying obesity. Int J Obes Relat Metab Disord 19 Suppl 7: S10-S16, 1995